デフォルト表紙
市場調査レポート
商品コード
1659045

ユーバイオティクスの世界市場レポート2025年

Eubiotics Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ユーバイオティクスの世界市場レポート2025年
出版日: 2025年02月18日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ユーバイオティクスの市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.8%で89億5,000万米ドルに成長します。予測期間の成長は、ユーバイオティクスブレンドの出現、持続可能な農業の傾向の高まり、酪農産業の拡大、馬の栄養用途、プレバイオティクスとポストバイオティクスの統合、抗生物質不使用製品に対する需要の高まりに起因すると考えられます。予測期間における主な動向としては、抗生物質成長促進剤(AGP)の代替、プレバイオティクスとプロバイオティクスの優位性、抗生物質削減に対する規制の重視、微生物ソリューションの進歩、持続可能で環境に優しい実践、水産養殖用途の拡大、共同研究やパートナーシップなどがあります。

ユーバイオティクス市場における家畜人口の増加は、予測期間中の市場成長を促進すると予想されます。家畜には、家畜種と野生種の両方を含む、商業目的で飼育される様々な品種の動物が含まれます。家畜数の増加は、牛乳、卵、鶏肉、繊維製品の販売などの商業活動への利用によるところが大きいです。例えば、2024年5月のブラジル地域統計研究所の報告書によると、ブラジルの豚・豚のと殺頭数は5,717万頭で、2024年第1四半期は1,392万頭と前年同期比1.8%の微減となった。とはいえ、ブラジルは依然として世界市場で重要な地位を占めており、特に中国や中東などの国々に大量の豚肉、鶏肉、牛肉を輸出しています。このように、商業目的での家畜利用の増加は、今後数年間のユーバイオティクス市場の成長を促進すると予想されます。

高品質の動物飼料に対する需要の高まりは、ユーバイオティクス市場の成長を加速させると予想されます。高品質の動物用飼料は、動物の特定の食事ニーズを満たすように調整された栄養バランスのとれた汚染物質フリーの製剤であり、最適な健康、成長、繁殖を促進します。ユーバイオティクスは現代の動物栄養学において重要な役割を担っており、動物の健康を増進し、抗生物質の使用を最小限に抑え、家畜生産システムの持続可能性を向上させるためにますます使用されるようになっています。例えば、飼料業界を代表する米国の非営利団体である米国飼料産業協会(American Feed Industry Association)は2023年、全米で約5,650の動物飼料製造施設が操業しており、年間2億8,400万トン以上の完成飼料とペットフードを生産していると報告しています。したがって、高品質の動物用飼料に対する需要の高まりが、ユーバイオティクス市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界のユーバイオティクス PESTEL分析(政治、社会、技術、環境、法的要因、促進要因、抑制要因)
  • 最終用途産業の分析
  • 世界のユーバイオティクス市場:成長率分析
  • 世界のユーバイオティクス市場の実績:規模と成長, 2019-2024
  • 世界のユーバイオティクス市場の予測:規模と成長, 2024-2029, 2034F
  • 世界のユーバイオティクス総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のユーバイオティクス市場:製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • プロバイオティクス
  • プレバイオティクス
  • 有機酸
  • エッセンシャルオイル
  • 酵素
  • 世界のユーバイオティクス市場:機能別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 腸と消化器の健康
  • 一般的な健康とウェルネス
  • 免疫
  • 世界のユーバイオティクス市場:形態別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ドライ
  • 液体
  • 世界のユーバイオティクス市場:家畜別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 家禽
  • 水産養殖
  • その他の家畜
  • 世界のユーバイオティクス市場:プロバイオティクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 細菌性プロバイオティクス
  • 酵母プロバイオティクス
  • 世界のユーバイオティクス市場:プレバイオティクスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • フルクトオリゴ糖(FOS)
  • ガラクトオリゴ糖(GOS)
  • イヌリン
  • 世界のユーバイオティクス市場:有機酸のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 乳酸
  • 酢酸
  • プロピオン酸
  • 世界のユーバイオティクス市場:エッセンシャルオイルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 植物由来のエッセンシャルオイル
  • 抗菌作用のある抽出物
  • 世界のユーバイオティクス市場:酵素のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 消化酵素
  • 飼料用酵素

第7章 地域別・国別分析

  • 世界のユーバイオティクス市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のユーバイオティクス市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ユーバイオティクス市場:競合情勢
  • ユーバイオティクス市場:企業プロファイル
    • BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • Koninklijke DSM NV Overview, Products and Services, Strategy and Financial Analysis
    • Lallemand Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novus International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Chr Hansen Holding A/S Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Cargill Inc.
  • Lesaffre Group
  • Kemin Industries Inc.
  • Evonik Industries AG
  • Archer Daniels Midland Company
  • Beneo GmbH
  • BioResource International Inc.
  • Biomin Holding GmbH
  • Bluestar Adisseo Company
  • Dupont Nutrition & Biosciences
  • Nutreco NV
  • Pancosma SA
  • Synbio Tech Inc.
  • Vetagro SpA
  • Zinpro Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • ユーバイオティクス市場2029:新たな機会を提供する国
  • ユーバイオティクス市場2029:新たな機会を提供するセグメント
  • ユーバイオティクス市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r22586

Eubiotics represent natural digestive feed supplements designed to enhance animal health and bolster immune system functionality. They incorporate a blend of food additives, including prebiotics, probiotics, and polysaccharides, aimed at supporting gut health, immune development, and maintaining optimal microflora in the gastrointestinal tract.

The primary categories of eubiotics encompass probiotics, prebiotics, organic acids, essential oils, and enzymes. Probiotics consist of live microorganisms that contribute to overall health, bolstering immunity and promoting digestive well-being. These microorganisms aid in improving immunity, digestion, gut health, and reducing microbial contamination. Eubiotics are available in various treatment forms such as dry and liquid formulations tailored for applications in livestock including cattle, poultry, swine, aquaculture, and other animals, catering to needs related to gut and digestive health, overall wellness, and immunity support in animals.

The eubiotics market research report is one of a series of new reports from The Business Research Company that provides eubiotics market statistics, including the eubiotics industry's global market size, regional shares, competitors with a eubiotics market share, detailed eubiotics market segments, market trends and opportunities, and any further data you may need to thrive in the eubiotics industry. This eubiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The eubiotics market size has grown strongly in recent years. It will grow from $5.85 billion in 2024 to $6.38 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to rising consumer awareness of healthy diets, focus on livestock health and performance, antibiotic resistance concerns, increasing meat consumption, research and development investments.

The eubiotics market size is expected to see strong growth in the next few years. It will grow to $8.95 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to emergence of eubiotic blends, growing trend of sustainable agriculture, expansion of dairy industry, application in horse nutrition, integration of prebiotics and postbiotics, rising demand for antibiotic-free products. Major trends in the forecast period include replacement of antibiotic growth promoters (AGPs), prebiotics and probiotics dominance, regulatory emphasis on antibiotic reduction, advancements in microbial solutions, sustainable and eco-friendly practices, and expansion in aquaculture applications, collaborations and partnerships.

The growing livestock population in the eubiotics market is expected to boost market growth during the forecast period. Livestock encompasses various breeds of animals raised for commercial purposes, including both domestic and wild species. The increase in livestock numbers is largely due to their use for commercial activities, such as the sale of milk, eggs, chicken, and fiber products. For example, in May 2024, a report from the Brazilian Institute of Geography and Statistics indicated that Brazil reported the slaughter of 57.17 million hogs and pigs, with a slight decline in Q1 2024 to 13.92 million, representing a 1.8% decrease compared to the same quarter in 2023. Nevertheless, Brazil remains a significant player in the global market, exporting large quantities of pork, chicken, and beef, particularly to countries like China and those in the Middle East. Thus, the increasing use of livestock for commercial purposes is expected to drive the growth of the eubiotics market in the coming years.

The rising demand for high-quality animal feeds is anticipated to accelerate the growth of the eubiotics market moving forward. High-quality animal feeds are nutritionally balanced, contaminant-free formulations tailored to meet the specific dietary needs of animals, promoting optimal health, growth, and reproduction. Eubiotics play a crucial role in modern animal nutrition, increasingly used to enhance animal health, minimize antibiotic use, and improve the sustainability of livestock production systems. For instance, in 2023, the American Feed Industry Association, a U.S.-based non-profit organization representing the feed industry, reported that there are nearly 5,650 animal food manufacturing facilities operating across the nation, producing over 284 million tons of finished feed and pet food annually. Therefore, the rising demand for high-quality animal feeds is driving the growth of the eubiotics market.

Product innovation is a significant trend in the eubiotics market, with major players concentrating on developing innovative products to enhance the quality of feed additives within eubiotic offerings. High-quality nutrients, like probiotics, serve as feed additives that improve animal performance by promoting gut health. For example, in October 2022, APC Europe S.L.U., a Spain-based company specializing in high-quality feed additives, introduced APPETEIN GS, a granulated plasma ingredient. This product is designed to improve flowability and reduce dust in feed formulations while consisting of pure porcine proteins, with the goal of enhancing animal welfare and intestinal health.

Key companies in the market are focused on creating innovative products, such as prebiotic fiber, to gain a competitive edge and expand their customer base. Prebiotic fiber is a specialized type of fiber that encourages the growth of beneficial gut bacteria. For instance, in September 2023, Alltech, a U.S.-based nutrition company, launched Microbuild, an advanced prebiotic fiber designed to promote gut health and support a strong microbiome in pets. This innovative prebiotic aims to enhance overall well-being and ensure gut health, even when faced with bacterial challenges. It does so by increasing microbial diversity in the gut, thereby strengthening the animal's natural defenses. As a nutritional technology, Microbuild assists pets in developing a diverse and healthy microbiome, providing noticeable benefits for pet owners who witness improvements in their pets' health. The strength of Microbuild lies in prebiotics, specialized fibers that stimulate the growth of beneficial gut bacteria. Improved fiber digestibility not only aids in nutrient absorption and maintains intestinal integrity but also helps in developing a strong immune system. Microbuild is based on the advanced field of nutrigenomics, which investigates the complex relationship between genetics and nutrition.

In March 2024, Novus International, Inc., a U.S.-based global provider of innovative nutritional solutions, acquired BioResource International, Inc. for an undisclosed sum. Novus International aims to enhance its enzyme product portfolio, strengthen its innovation pipeline, improve supply chain management, support gut health initiatives, and better serve its customers in the animal nutrition sector. BioResource International, Inc. is a U.S.-based biotechnology company that develops enzyme products designed to improve animal nutrition, closely aligning with eubiotic principles to promote gut health in livestock.

Major companies operating in the eubiotics market are BASF SE, Koninklijke DSM NV, Lallemand Inc., Novus International Inc., Chr Hansen Holding A/S, Cargill Inc., Lesaffre Group, Kemin Industries Inc., Evonik Industries AG, Archer Daniels Midland Company, Beneo GmbH, BioResource International Inc., Biomin Holding GmbH, Bluestar Adisseo Company, Dupont Nutrition & Biosciences, Nutreco NV, Pancosma SA, Synbio Tech Inc., Vetagro SpA, Zinpro Corporation, Alltech Inc., Impextraco NV, Nuscience Group, Olmix Group

Europe was the largest region in the eubiotics market in 2024. The regions covered in the eubiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the eubiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The eubiotics market consists of sales of lactobacilli, bifidobacterium, streptococcus, fructo-oligosaccharides (FOS), inulin, galacto-oligosaccharides (GOS), and mannan-oligosaccharides (MOS). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Eubiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on eubiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for eubiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The eubiotics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Probiotics; Prebiotics; Organic Acids; Essential Oils; Enzymes
  • 2) By Function: Gut And Digestive Health; General Health And Wellness; Immunity
  • 3) By Form: Dry; Liquid
  • 4) By Livestock: Cattle; Poultry; Swine; Aquaculture; Other Livestock
  • Subsegments:
  • 1) By Probiotics: Bacterial Probiotics; Yeast Probiotics
  • 2) By Prebiotics: Fructooligosaccharides (FOS); Galactooligosaccharides (GOS); Inulin
  • 3) By Organic Acids: Lactic Acid; Acetic Acid; Propionic Acid
  • 4) By Essential Oils: Plant-Derived Essential Oils; Extracts With Antimicrobial Properties
  • 5) By Enzymes: Digestive Enzymes; Feed Enzymes
  • Companies Mentioned: BASF SE; Koninklijke DSM NV; Lallemand Inc.; Novus International Inc.; Chr Hansen Holding A/S
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Eubiotics Market Characteristics

3. Eubiotics Market Trends And Strategies

4. Eubiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Eubiotics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Eubiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Eubiotics Market Growth Rate Analysis
  • 5.4. Global Eubiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Eubiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Eubiotics Total Addressable Market (TAM)

6. Eubiotics Market Segmentation

  • 6.1. Global Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Probiotics
  • Prebiotics
  • Organic Acids
  • Essential Oils
  • Enzymes
  • 6.2. Global Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gut And Digestive Health
  • General Health And Wellness
  • Immunity
  • 6.3. Global Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Dry
  • Liquid
  • 6.4. Global Eubiotics Market, Segmentation By Livestock, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cattle
  • Poultry
  • Swine
  • Aquaculture
  • Other Livestock
  • 6.5. Global Eubiotics Market, Sub-Segmentation Of Probiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bacterial Probiotics
  • Yeast Probiotics
  • 6.6. Global Eubiotics Market, Sub-Segmentation Of Prebiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fructooligosaccharides (FOS)
  • Galactooligosaccharides (GOS)
  • Inulin
  • 6.7. Global Eubiotics Market, Sub-Segmentation Of Organic Acids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Lactic Acid
  • Acetic Acid
  • Propionic Acid
  • 6.8. Global Eubiotics Market, Sub-Segmentation Of Essential Oils, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Plant-Derived Essential Oils
  • Extracts With Antimicrobial Properties
  • 6.9. Global Eubiotics Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Digestive Enzymes
  • Feed Enzymes

7. Eubiotics Market Regional And Country Analysis

  • 7.1. Global Eubiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Eubiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Eubiotics Market

  • 8.1. Asia-Pacific Eubiotics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Eubiotics Market

  • 9.1. China Eubiotics Market Overview
  • 9.2. China Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Eubiotics Market

  • 10.1. India Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Eubiotics Market

  • 11.1. Japan Eubiotics Market Overview
  • 11.2. Japan Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Eubiotics Market

  • 12.1. Australia Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Eubiotics Market

  • 13.1. Indonesia Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Eubiotics Market

  • 14.1. South Korea Eubiotics Market Overview
  • 14.2. South Korea Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Eubiotics Market

  • 15.1. Western Europe Eubiotics Market Overview
  • 15.2. Western Europe Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Eubiotics Market

  • 16.1. UK Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Eubiotics Market

  • 17.1. Germany Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Eubiotics Market

  • 18.1. France Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Eubiotics Market

  • 19.1. Italy Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Eubiotics Market

  • 20.1. Spain Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Eubiotics Market

  • 21.1. Eastern Europe Eubiotics Market Overview
  • 21.2. Eastern Europe Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Eubiotics Market

  • 22.1. Russia Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Eubiotics Market

  • 23.1. North America Eubiotics Market Overview
  • 23.2. North America Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Eubiotics Market

  • 24.1. USA Eubiotics Market Overview
  • 24.2. USA Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Eubiotics Market

  • 25.1. Canada Eubiotics Market Overview
  • 25.2. Canada Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Eubiotics Market

  • 26.1. South America Eubiotics Market Overview
  • 26.2. South America Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Eubiotics Market

  • 27.1. Brazil Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Eubiotics Market

  • 28.1. Middle East Eubiotics Market Overview
  • 28.2. Middle East Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Eubiotics Market

  • 29.1. Africa Eubiotics Market Overview
  • 29.2. Africa Eubiotics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Eubiotics Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Eubiotics Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Eubiotics Market Competitive Landscape And Company Profiles

  • 30.1. Eubiotics Market Competitive Landscape
  • 30.2. Eubiotics Market Company Profiles
    • 30.2.1. BASF SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Koninklijke DSM NV Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Lallemand Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Novus International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Chr Hansen Holding A/S Overview, Products and Services, Strategy and Financial Analysis

31. Eubiotics Market Other Major And Innovative Companies

  • 31.1. Cargill Inc.
  • 31.2. Lesaffre Group
  • 31.3. Kemin Industries Inc.
  • 31.4. Evonik Industries AG
  • 31.5. Archer Daniels Midland Company
  • 31.6. Beneo GmbH
  • 31.7. BioResource International Inc.
  • 31.8. Biomin Holding GmbH
  • 31.9. Bluestar Adisseo Company
  • 31.10. Dupont Nutrition & Biosciences
  • 31.11. Nutreco NV
  • 31.12. Pancosma SA
  • 31.13. Synbio Tech Inc.
  • 31.14. Vetagro SpA
  • 31.15. Zinpro Corporation

32. Global Eubiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Eubiotics Market

34. Recent Developments In The Eubiotics Market

35. Eubiotics Market High Potential Countries, Segments and Strategies

  • 35.1 Eubiotics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Eubiotics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Eubiotics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer